Efficacy of individualized homoeopathic medicines in the symptomatic improvement of menopausal syndrome: A double-blind, randomized, placebo-controlled trial - Nil

D. N. De Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月29日

试验速览

暂无简介。

•1. Patients suffering from Menopausal syndrome (ICD-11-GA30.0) presenting with symptoms (hot flashes, mood changes, vaginal dryness, sleep disturbances, etc.) of not less than 3 months of duration
•2. Age between 40 and 55 years
•3. Mild to moderate menopausal symptoms - MRS score mild 5-8, moderate 9-16
•4. Participants having prior experience or knowledge of the treatment; e.g., primed to expect ‘homoeopathic aggravation’ and available treatment options for the disease conditions, intimated through Patient Information Sheet

•1. Not willing to give informed consent or to comply with the study procedure.
•2. Hysterectomy done and/or receiving any kind of hormone therapy.
•3. Any life-threatening diseases or recently active physical disease.
•4. In some condition when requiring emergency or surgical intervention.
•5. Presence of uncontrolled medical conditions such as diabetes, hypertension, cardiac disorder & thyroid disorder.
•6. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life.
•7. Undergoing homoeopathic treatment for any chronic disease within last six months.
•8. Simultaneous participation in any other clinical trial.
•9. Vulnerable population - Unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, mentally incompetent people.
•10. Self-reported immune-compromised state.
•11. Tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence

发起方

D. N. De Homoeopathic Medical College and Hospital